| Tyyppi : |
Lehti |
| Internet-yhteys : |
https://doi.org/10.1515/pthp-2020-0013 |
|
| Tutkimus Joukkueet : |
Angers - University Hospital of Angers, Pharmacy Department |
| Tekijät : |
Lebreton V, Bourcier B, Cosson K, Lagarce F, Spiesser-Robelet L, Vrignaud S. |
| Otsikko : |
New liquid oral formulations of hydroxychloroquine: a physicochemical stability study. |
| Numero : |
Pharmaceutical Technology in Hospital Pharmacy ; 6(1): 20200013. 2021 |
|
| Todisteiden määrä : |
|
| Fyysinen vakaus : |
|
| Kemiallinen stabiilisuus : |
|
| Muut menetelmät : |
|
| Commentairesvaleur : |
|
Luettelo yhdisteistä
 Hydroxychloroquine sulfate
|
 |
 |
 |
 |
1500 mg
Plaquenil® |
| SyrSpend SF PH4® |
>> 30 mL |
|
2-8°C |
 |
| 90 |
 |
|
|
|
|
|
1500 mg
Plaquenil® |
| OraPlus® / OraSweet® (1:1) |
>> 30 mL |
|
2-8°C |
|
| 90 |
|
|
|
|
|
|
1500 mg
Plaquenil® |
| SyrSpend SF PH4® |
>> 30 mL |
|
28-32°C |
|
| 60 |
|
|
|
|
|
|
1500 mg
Plaquenil® |
| OraPlus® / OraSweet® (1:1) |
>> 30 mL |
|
28-32°C |
|
| 90 |
|
|
|
|
|
